Friday, July 10, 2026

pharma · Ovarian Neoplasms · Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer

TESARO Bio Netherlands

TESARO Bio Netherlands trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
6
Drugs
23
Patents
0
Intelligence · Clinical Trials

TESARO Bio Netherlands clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to TESARO Bio Netherlands programs — each row shows trial ID, program name, phase, status, and indication.

TESARO Bio Netherlands trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for TESARO Bio Netherlands.

  1. PR-30-5017-C — Phase 3

    Clinical update
  2. AMBER — Phase 1

    Clinical update
  3. 4010-01-001 — Phase 1

    Clinical update
  4. 213357 — Phase 2

    Clinical update
  5. 213350/3000-03-005 — Phase 3

    Clinical update
  6. 4010-03-001 — Phase 3

    Clinical update

Trial registry

6 studies